"ErbB Receptors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of structurally-related cell-surface receptors that signal through an intrinsic PROTEIN-TYROSINE KINASE. The receptors are activated upon binding of specific ligands which include EPIDERMAL GROWTH FACTORS, and NEUREGULINS.
| Descriptor ID |
D066246
|
| MeSH Number(s) |
D08.811.913.696.620.682.725.400.009 D12.776.543.750.630.009 D12.776.543.750.750.400.074
|
| Concept/Terms |
ErbB Receptors- ErbB Receptors
- Receptors, ErbB
- Receptors, Epidermal Growth Factor-Urogastrone
- Receptors, Epidermal Growth Factor Urogastrone
- Receptors, Epidermal Growth Factor
- EGF Receptors
- Receptors, EGF
- Epidermal Growth Factor Receptor Family Proteins
- HER Family Receptors
- Family Receptors, HER
- Receptors, HER Family
- Erb-b2 Receptor Tyrosine Kinases
- Erb b2 Receptor Tyrosine Kinases
|
Below are MeSH descriptors whose meaning is more general than "ErbB Receptors".
Below are MeSH descriptors whose meaning is more specific than "ErbB Receptors".
This graph shows the total number of publications written about "ErbB Receptors" by people in this website by year, and whether "ErbB Receptors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 2 | 4 |
| 1998 | 0 | 1 | 1 |
| 2000 | 2 | 1 | 3 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 3 | 1 | 4 |
| 2004 | 5 | 5 | 10 |
| 2005 | 2 | 4 | 6 |
| 2006 | 4 | 6 | 10 |
| 2007 | 7 | 1 | 8 |
| 2008 | 2 | 3 | 5 |
| 2009 | 1 | 5 | 6 |
| 2010 | 9 | 5 | 14 |
| 2011 | 6 | 8 | 14 |
| 2012 | 2 | 5 | 7 |
| 2013 | 8 | 0 | 8 |
| 2014 | 5 | 4 | 9 |
| 2015 | 8 | 4 | 12 |
| 2016 | 2 | 4 | 6 |
| 2017 | 3 | 3 | 6 |
| 2018 | 2 | 5 | 7 |
| 2019 | 1 | 10 | 11 |
| 2020 | 0 | 7 | 7 |
| 2021 | 2 | 3 | 5 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 3 | 3 |
| 2024 | 2 | 2 | 4 |
| 2025 | 0 | 5 | 5 |
| 2026 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "ErbB Receptors" by people in Profiles.
-
Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity. Clin Cancer Res. 2026 Nov 02; 32(21):4956-4974.
-
p63 and p73 drive cutaneous squamous cell carcinoma through convergent transcriptional control of EGFR signaling. Cell Rep. 2026 Oct 27; 45(10):118030.
-
Loss of NCOA6 protein causes aggressive prostate cancer with EGFR overexpression and dependency. Nat Commun. 2026 09 15; 17(1).
-
Loss of ZNRF3/RNF43 unleashes EGFR in cancer. Elife. 2026 Apr 10; 13.
-
Ocular Surface Ulceration Associated With an Epidermal Growth Factor Receptor Inhibitor. Cornea. 2026 Jul 01; 45(7):937-939.
-
EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridge. Nat Commun. 2026 Jan 14; 17(1):1726.
-
Osimertinib activates a TGF-?2-dependent secretory program that drives lung adenocarcinoma progression. J Clin Invest. 2026 02 02; 136(3).
-
Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases. J Thorac Oncol. 2026 03; 21(3):103505.
-
Outcomes After Radiation for Oligoprogressive Disease Sites in Patients With EGFR-Mutant Lung Cancer Treated With Osimertinib. JCO Precis Oncol. 2025 May; 9:e2500047.
-
Multi-omics delineate growth factor network underlying exercise effects in an Alzheimer's mouse model. Alzheimers Dement. 2025 03; 21(3):e70024.